{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:59:53Z","timestamp":1778741993790,"version":"3.51.4"},"reference-count":61,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T00:00:00Z","timestamp":1294358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is a persisting challenge to clinical and basic research scientists as none of the presently available medications have been fully able to combat these consequences. The aim of the present review is to summarize the different lines of treatment available for the different symptomologies that women with PCOS presents. In this comprehensive review, search was made for various treatment options available for PCOS by using Cochrane library, Pubmed, Medline, in addition to the relevant printed medical journals and periodicals. The search results revealed that oral contraceptives containing oestrogen and progesterone regularize the menstruation, antiandrogens like spironolactone and drosperinone have proven to be effective in hirsutism and acne, clomiphene is the gold standard for ovulation induction, but multiple pregnancies and clomiphene failure add to its limitation. Hence, aromatase inhibitors like letrozole, low\u2010dose gondotropins, and ovarian drilling procedure have shown to be beneficial effect in clomiphene\u2010resistant cases. Insulin sensitizers such as metformin, thiazolidinediones, and <jats:sc>d<\/jats:sc>\u2010chiro\u2010inositol increase insulin sensitivity and improve ovulation rate. Recently, melatonin, N\u2010acetyl cysteine, acarbose, and statins have shown positive results in different symptomologies of PCOS. The results show that PCOS treatment constitutes varied line of treatment depending upon the clinical features with which a woman is presenting. Still, unfortunately, none of the treatments are fully able to combat the PCOS.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2010.00916.x","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T10:04:50Z","timestamp":1294394690000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacotherapy of polycystic ovary syndrome \u2013 an update"],"prefix":"10.1111","volume":"26","author":[{"given":"Lekha","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharonjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip Kumar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,7]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1457"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041536"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0628"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1329"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345554"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.03.051"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/gye.16.6.443.446"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2153"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.165"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.141"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-006-0056-1"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1843"},{"key":"e_1_2_11_16_2","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon C.G.","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1666"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem426"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2001.tb143439.x"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13409-5"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi005"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi054"},{"key":"e_1_2_11_24_2","unstructured":"NICE guidelines published in February 2004.http:\/\/www.google.com."},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)34504-2"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2006.03.002"},{"key":"e_1_2_11_27_2","first-page":"CD002249","article-title":"Oral anti\u2010oestrogens and medical adjuncts for subfertility associated with anovulation","volume":"1","author":"Beck J.I.","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del267"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)62070-6"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1923"},{"key":"e_1_2_11_31_2","first-page":"CD000410","article-title":"Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome","volume":"4","author":"Nugent D.","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_32_2","first-page":"CD002121","article-title":"Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome","volume":"2","author":"Bayram N.","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)61273-4"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg336"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)61747-6"},{"key":"e_1_2_11_36_2","article-title":"Laparoscopic \u2018drilling\u2019 by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","volume":"1","author":"Farquhar C.","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.4.1626"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401703"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.951"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04925-7"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)01975-6"},{"key":"e_1_2_11_42_2","first-page":"CD003053","article-title":"Insulin\u2010sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for polycystic ovary syndrome","volume":"3","author":"Lord J.M.","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_43_2","first-page":"CD003053","article-title":"Insulin\u2010sensitising drugs (metformin, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for women with polycystic ovary syndrome, oligoamenorrhoea and subfertility","volume":"1","author":"Tang T.","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S6864"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.06.022"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13493-9"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014"},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1696"},{"key":"e_1_2_11_49_2","first-page":"722","article-title":"Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles","volume":"52","author":"Yildirim B.","year":"2007","journal-title":"J. Reprod. Med."},{"key":"e_1_2_11_50_2","first-page":"476","article-title":"Expression of novel apoptosis\u2010related protein PDCD5 in granulosa cells of polycystic ovary syndrome","volume":"37","author":"Sun C.L.","year":"2005","journal-title":"Beijing Da. Xue. Xue. Bao."},{"key":"e_1_2_11_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.05.016"},{"key":"e_1_2_11_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03133-3"},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.03.002"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.07.960"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016340601090337"},{"key":"e_1_2_11_56_2","first-page":"66","article-title":"N acetyl cysteine, a novel remedy for poly cystic ovarian syndrome","volume":"3","author":"Salehpour S.","year":"2009","journal-title":"Int. J. Fertil. Steril."},{"key":"e_1_2_11_57_2","unstructured":"Acarbose.Lexi\u2010Comp Online.http:\/\/online.lexi.com\/crlonline(accessed 2010 Feb 10)."},{"key":"e_1_2_11_58_2","first-page":"1613","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"Davis S.N.","year":"2006"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh580"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei104"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.11.073"},{"key":"e_1_2_11_62_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-992933"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2010.00916.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2010.00916.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T19:53:35Z","timestamp":1698695615000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2010.00916.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1472-8206.2010.00916.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00916.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,7]]},"assertion":[{"value":"2011-01-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}